PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34150623-6	2021	Lovastatin inhibited EMT as demonstrated by down-regulation of the protein levels of Vimentin and Twist in MDA-MB-231 CSCs in vitro and vivo and by reversal of TGF-beta1-induced morphological change in MCF10A cells.	Lovastatin	0-10	vimentin	Homo sapiens	85-93	
25742642-4	2015	Cotreatment with troglitazone and lovastatin altered the epithelial-to-mesenchymal-transition (EMT) -related marker gene expression of the cells; specifically, E-cadherin expression increased and vimentin expression decreased.	Lovastatin	34-44	vimentin	Homo sapiens	196-204	
26517522-7	2016	Quantitative real time PCR, fluorescent microscopy, and cell migration assays all confirmed that Lovastatin inhibits integrin alphavbeta3 downstream signaling including FAK activation, and beta-catenin, vimentin, ZO-1, and beta-actin.	Lovastatin	97-107	vimentin	Homo sapiens	203-211